MedPath

Alprazolam

Alprazolam Tablets, USP CIV

Approved
Approval ID

9af2f55c-f624-6fe9-e053-2a95a90ace0c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 30, 2019

Manufacturers
FDA

medsource pharmaceuticals

DUNS: 833685915

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Alprazolam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code45865-993
Application NumberANDA207507
Product Classification
M
Marketing Category
C73584
G
Generic Name
Alprazolam
Product Specifications
Route of AdministrationORAL
Effective DateDecember 30, 2019
FDA Product Classification

INGREDIENTS (8)

ALPRAZOLAMActive
Quantity: 0.5 mg in 1 1
Code: YU55MQ3IZY
Classification: ACTIB
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A CORNInactive
Code: AG9B65PV6B
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Alprazolam - FDA Drug Approval Details